Theresa S Emory, MD | |
500 J Clyde Morris Blvd, Newport News, VA 23601-1929 | |
(757) 594-2160 | |
Not Available |
Full Name | Theresa S Emory |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 35 Years |
Location | 500 J Clyde Morris Blvd, Newport News, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639155492 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 0101052408 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Riverside Regional Medical Center | Newport news, VA | Hospital |
Riverside Walter Reed Hospital | Gloucester, VA | Hospital |
Riverside Shore Memorial Hospital | Onancock, VA | Hospital |
Sentara Williamsburg Regional Medical Center | Williamsburg, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Peninsula Pathology Associates Incorporated | 2264496009 | 5 |
News Archive
Researchers at the Division of Infection and Immunity, University College London, UK, have provided key insights into the characteristics of the B.1.1.7 (or UK) variant of SARS-CoV-2.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company's clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.
Do your palms sweat when you walk down a poorly lit street at night? That feeling may be traced to the firing of newly identified "anxiety" cells deep inside your brain, according to new research from neuroscientists at Columbia University Irving Medical Center and the University of California, San Francisco.
Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the launch of Mefoxin® (cefoxitin injection) frozen premix bags. The launch marks the company's first product offering to be supplied in a frozen premix bag presentation. Mefoxin (cefoxitin injection) is manufactured by Baxter Healthcare Corporation using Baxter's proprietary GALAXY container technology.
Patients with heart failure often have a buildup of scar tissue that leads to a gradual loss of heart function. In a new study published today in the journal Cell Stem Cell, researchers from the University of North Carolina School of Medicine report significant progress toward a novel approach that could shrink the amount of heart scar tissue while replenishing the supply of healthy heart muscle.
› Verified 3 days ago
Entity Name | Peninsula Pathology Associates Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306834858 PECOS PAC ID: 2264496009 Enrollment ID: O20080703000273 |
News Archive
Researchers at the Division of Infection and Immunity, University College London, UK, have provided key insights into the characteristics of the B.1.1.7 (or UK) variant of SARS-CoV-2.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company's clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.
Do your palms sweat when you walk down a poorly lit street at night? That feeling may be traced to the firing of newly identified "anxiety" cells deep inside your brain, according to new research from neuroscientists at Columbia University Irving Medical Center and the University of California, San Francisco.
Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the launch of Mefoxin® (cefoxitin injection) frozen premix bags. The launch marks the company's first product offering to be supplied in a frozen premix bag presentation. Mefoxin (cefoxitin injection) is manufactured by Baxter Healthcare Corporation using Baxter's proprietary GALAXY container technology.
Patients with heart failure often have a buildup of scar tissue that leads to a gradual loss of heart function. In a new study published today in the journal Cell Stem Cell, researchers from the University of North Carolina School of Medicine report significant progress toward a novel approach that could shrink the amount of heart scar tissue while replenishing the supply of healthy heart muscle.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Theresa S Emory, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | Theresa S Emory, MD 500 J Clyde Morris Blvd, Newport News, VA 23601-1929 Ph: (757) 594-2160 |
News Archive
Researchers at the Division of Infection and Immunity, University College London, UK, have provided key insights into the characteristics of the B.1.1.7 (or UK) variant of SARS-CoV-2.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company's clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.
Do your palms sweat when you walk down a poorly lit street at night? That feeling may be traced to the firing of newly identified "anxiety" cells deep inside your brain, according to new research from neuroscientists at Columbia University Irving Medical Center and the University of California, San Francisco.
Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the launch of Mefoxin® (cefoxitin injection) frozen premix bags. The launch marks the company's first product offering to be supplied in a frozen premix bag presentation. Mefoxin (cefoxitin injection) is manufactured by Baxter Healthcare Corporation using Baxter's proprietary GALAXY container technology.
Patients with heart failure often have a buildup of scar tissue that leads to a gradual loss of heart function. In a new study published today in the journal Cell Stem Cell, researchers from the University of North Carolina School of Medicine report significant progress toward a novel approach that could shrink the amount of heart scar tissue while replenishing the supply of healthy heart muscle.
› Verified 3 days ago
Dr. John Coulter Maddox, MD Pathology Medicare: Medicare Enrolled Practice Location: 500 J Clyde Morris Blvd, Newport News, VA 23601 Phone: 757-594-2160 | |
Dr. Carolyn Fawn O'connor, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 500 J Clyde Morris Blvd, Newport News, VA 23601 Phone: 757-594-2160 | |
Dr. David Michael Smith, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 500 J Clyde Morris Blvd, Newport News, VA 23601 Phone: 757-594-2160 | |
Jonathan Edwards, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: Bon Secours Mary Immaculate Hospital, Pathology Dept, 2 Bernardine Dr, Newport News, VA 23602 Phone: 240-678-5454 | |
Lucy Elena Defanti, Pathology Medicare: Accepting Medicare Assignments Practice Location: 500 J Clyde Morris Blvd, Newport News, VA 23601 Phone: 757-594-2160 | |
Dr. Warren Bowman Helwig, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 500 J Clyde Morris Blvd, Newport News, VA 23601 Phone: 757-594-3160 |